Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Natrol

This article was originally published in The Tan Sheet

Executive Summary

FlexAnew TV ads to break Sept. 24 on network, syndicated channels. Spots will join ongoing print ads, sampling, in-store displays as part of roughly $3 mil. promotional spend. Glucosamine/chondroitin supplement for joint health, which launched in May, is available in nearly 25,000 retail stores nationwide, firm notes (1"The Tan Sheet" May 21, p. 6)

You may also be interested in...



Natrol Fiber, Cleansing Teas Headline New Product Launches

Fiberlicious, a new easily dissolved high-fiber tea from Natrol, is one of several products the firm is rolling out for early summer.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

OM013164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel